Estrogen receptor polymorphisms in tamoxifen-treated women with breast cancer

By Georgopoulos Neoklis   Adonakis George   Fotopoulos Andreas   Koika Vasiliki   Spinos Nikitas   Saltamavros Alexandros   Keramopoulos Antonios   Koukouras Dimitrios   Decavalas George   Kourounis George  

Gynecological Endocrinology, Vol. 22, Iss. 4, 2006-04 ,pp. : 185-189

Informa Healthcare

Access to resources Recommend Favorite

Black cohosh (Cimicifuga racemosa) in tamoxifen-treated breast cancer patients with climacteric complaints – a prospective observational study

By Rostock Matthias   Fischer Julia   Mumm Andreas   Stammwitz Ute   Saller Reinhard   Bartsch Hans Helge  

Gynecological Endocrinology, Vol. 27, Iss. 10, 2011-10 ,pp. : 844-848

Informa Healthcare

Access to resources Recommend Favorite

Immunology. The distribution of endometrial leukocytes and their proliferation markers in trimegestone-treated postmenopausal women compared to the endometrium of the natural cycle: a dose-ranging study

By Wahab May   Thompson John  

Human Reproduction, Vol. 14, Iss. 5, 1999-05 ,pp. : 1201-1206

Oxford University Press

Access to resources Recommend Favorite

The Value of Transvaginal Ultrasonography in the Endometrial Evaluation of Breast Cancer Patients Using Tamoxifen

By  

Medical Principles and Practice, Vol. 19, Iss. 3, 2010-03 ,pp. : 222-227

Karger

Access to resources Recommend Favorite

Accuracy of transvaginal ultrasound in diagnosing endometrial pathology in women with post-menopausal bleeding on tamoxifen

By Weaver J   McHugo J M   Clark T J  

British Journal of Radiology, Vol. 78, Iss. 929, 2005-05 ,pp. : 394-397

British Institute of Radiology

Access to resources Recommend Favorite